NFSG
FLGT icon

Newbridge Financial Services Group’s Fulgent Genetics FLGT Stock Holding History

Newbridge Financial Services Group’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-178
Closed -$7K – 1465
2022
Q3 		$7K Hold
178
– – ﹤0.01% 968
2022
Q2 		$10K Hold
178
– – 0.01% 860
2022
Q1 		$11K Buy
+178
New +$11.7K 0.01% 911
2021
Q2 		– Sell
-200
Closed -$19K – 1453
2021
Q1 		$19K Buy
+200
New +$20.6K 0.01% 704

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Newbridge Financial Services Group's FLGT Position: Q4 2022 in Review

Newbridge Financial Services Group sold out of Fulgent Genetics (FLGT) in Q4 2022, closing a stake of 178 shares — an estimated $7K sold.

Newbridge Financial Services Group first reported a position in FLGT in Q1 2021 and held it in 4 quarters. The position peaked at $19K in Q1 2021. 224 funds tracked by Wall St. Rank hold FLGT as of Q4 2022.

  • Newbridge Financial Services Group reported no remaining Fulgent Genetics position as of Q4 2022 after selling out during the quarter.
  • Newbridge Financial Services Group sold 178 Fulgent Genetics shares in Q4 2022, an estimated $7K.
  • Newbridge Financial Services Group first reported a position in Fulgent Genetics in Q1 2021 and held it in 4 quarters.
  • Newbridge Financial Services Group's Fulgent Genetics position peaked at $19K in Q1 2021.
  • 224 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2022.

Based on Newbridge Financial Services Group's 13F filing for Q4 2022, filed 17 Jan 2023.